0001104659-21-137694.txt : 20211112
0001104659-21-137694.hdr.sgml : 20211112
20211112095217
ACCESSION NUMBER: 0001104659-21-137694
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20210930
FILED AS OF DATE: 20211112
DATE AS OF CHANGE: 20211112
EFFECTIVENESS DATE: 20211112
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Foresite Capital Management I, LLC
CENTRAL INDEX KEY: 0001581219
IRS NUMBER: 800843062
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-15934
FILM NUMBER: 211400740
BUSINESS ADDRESS:
STREET 1: 900 LARKSPUR LANDING CIRCLE, SUITE 150
CITY: LARKSPUR
STATE: CA
ZIP: 94939
BUSINESS PHONE: 415-877-4887
MAIL ADDRESS:
STREET 1: 900 LARKSPUR LANDING CIRCLE, SUITE 150
CITY: LARKSPUR
STATE: CA
ZIP: 94939
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
false
false
0001581219
XXXXXXXX
09-30-2021
09-30-2021
false
Foresite Capital Management I, LLC
900 Larkspur Landing Circle, Suite 150
Larkspur
CA
94939
13F HOLDINGS REPORT
028-15934
N
James B. Tananbaum
Managing Member
415-877-4887
/s/ James B. Tananbaum
San Francisco
CA
11-12-2021
0
4
127826
INFORMATION TABLE
2
infotable.xml
10X Genomics, Inc.
CLASS A COMMON
88025U109
109185
750000
SH
SOLE
750000
0
0
Acceleron Pharma Inc.
COM
00434H108
3287
19100
SH
SOLE
19100
0
0
Epizyme, Inc.
COM
29428V104
1504
293759
SH
SOLE
293759
0
0
Novavax, Inc.
COM
670002401
13850
66810
SH
SOLE
66810
0
0